IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q2 2020 Results - Earnings Call Transcript
ImmunoGen, Inc. (IMGN)
Q2 2020 Results Earnings Conference Call
July 31, 2020, 08:00 AM ET
Company Participants
Courtney O'Konek - Senior Director, Corporate Communications and Investor Relations
Mark Enyedy - President and Chief Executive Officer
Susan Altschuller - Senior Vice President and Chief Financial Officer
Anna Berkenblit - Senior Vice President, Chief Medical Officer
Conference Call Participants
John Newman - Canaccord Genuity
Kennen MacKay - RBC Capital Markets
Andy Hsieh - William Blair & Company
Aaron Welch - HC Wainwright & Co.
Biren Amin - Jefferies & Company, Inc.
Boris Peaker - Cowen and Company